NVCTNuvectis Pharma, Inc.
$20.13+229% 1Y
$20.13
$5.6552 weeks$28.52
Is it safe?
Watch
1 to watch, 5 without dataBig price swings. That is the only one of 6 checks this filer's data supports, so take it as a single data point rather than a settled answer.
Drawdown risk90% volderived · Oct 8, 2026
Large price swings, high volatility. Worst drawdown -78% · now 29% below its 52-week high.
Where this answer is blind. Altman sits structurally low for utilities and pipelines; Beneish runs high for fast growers, since sales growth alone lifts it; banks and REITs are excluded.
Can NVCT take a bad year?
The deepest fall in NVCT's price history on file is −78%; it is 29% below its high today.
−78%
Worst drawdown on file · −29% today
- Annualised volatility
- 90%
Annualised volatility · three times the market's own swing
Details›
- Cash and short-term investments
- $22M
- Operating profit, trailing twelve months
- −$29M
- Annualised volatilitytwo years of daily moves
- 90%
- Worst drawdown on file
- −78%
- Below its 52-week high
- 29%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.